| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Beck J |
MDMA: The popularization and resultant implications of a recently cont... |
Contemporary Drug Pr... |
1986 |
| Buffum J, Moser C |
MDMA and human sexual function |
J Psychoactive Drugs |
1986 |
| Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
| Grinspoon L, Bakalar JB |
Can drugs be used to enhance the psychotherapeutic process? |
Am J Psychother |
1986 |
| Siegel RK |
MDMA-Nonmedical use and intoxication |
J Psychoactive Drugs |
1986 |
| Davis WM, Hatoum HT, Wate... |
Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... |
Alcohol Drug Res |
1987 |
| Ricaurte GA, Forno LS, Wi... |
(+/-)3,4-Methylenedioxymethamphetamine selectively damages central ser... |
JAMA |
1988 |
| Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
| Slikker W Jr, Ali SF, Sca... |
Neurochemical and neurohistological alterations in the rat and monkey ... |
Toxicol Appl Pharmac... |
1988 |
| Peroutka SJ |
'Ecstasy': a human neurotoxin? |
Arch Gen Psychiatry |
1989 |
| Whitaker-Azmitia PM, Aron... |
'Ecstasy' (MDMA)-induced panic |
Am J Psychiatry |
1989 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| McKenna DJ, Peroutka SJ |
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... |
J Neurochem |
1990 |
| Greer GR,Tolbert R |
The Therapeutic Use of MDMA |
Ecstasy: The clinica... |
1990 |
| Grob CS, Bravo GL, Walsh ... |
The MDMA-neurotoxicity controversy: implications for clinical research... |
J Nerv Ment Dis |
1992 |
| Liester MB, Grob CS, Brav... |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use |
J Nerv Ment Dis |
1992 |
| Stolaroff MJ, Wells CW |
Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 |
Yearbook for Ethnome... |
1993 |
| Barrett PJ |
'Ecstasy' misuse--overdose or normal dose? |
Anaesthesia |
1993 |
| Shulgin A |
The new psychotherapy: MDMA and the shadow |
Eleusis |
1995 |
| Dar KJ, McBrien ME |
MDMA induced hyperthermia: report of a fatality and review of current ... |
Intensive Care Med |
1996 |
| Kintz P, Tracqui A, Mangi... |
Sweat testing in opioid users with a sweat patch |
J Anal Toxicol |
1996 |
| White JM, Bochner F, Irvi... |
The agony of 'ecstasy' |
Med J Aust |
1997 |
| Mallick A, Bodenham AR |
MDMA induced hyperthermia: a survivor with an initial body temperature... |
J Accid Emerg Med |
1997 |
| Spatt J, Glawar B, Mamoli... |
A pure amnestic syndrome after MDMA ('ecstasy') ingestion |
J Neurol Neurosurg P... |
1997 |
| Holland J |
Positron emission tomography findings in heavy users of MDMA |
Lancet |
1999 |
| Mithoefer MC, Brady K. |
A Human Pilot Study - Safety and Efficacy of 3,4-Methylenedioxymethamp... |
|
2001 |
| Doblin RE |
A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic s... |
J Psychoactive Drugs |
2002 |
| Young R, Glennon RA |
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinol... |
Pharmacol Biochem Be... |
2002 |
| Hurley RA, Reneman L, Tab... |
Ecstasy in the brain: a model for neuroimaging |
J Neuropsychiatry Cl... |
2002 |
| Holden C |
Drug find could give ravers the jitters |
Science |
2002 |
| Schifano F, Leoni M, Mart... |
Importance of cyberspace for the assessment of the drug abuse market: ... |
Cyberpsychol Behav |
2003 |
| Sessa B |
Is there a case for MDMA-assisted psychotherapy in the UK? |
J Psychopharmacol |
2007 |
| Sessa B, Nutt DJ |
MDMA, politics and medical research: have we thrown the baby out with ... |
J Psychopharmacol |
2007 |
| Tupper KW |
Entheogenic healing: The spiritual effects and therapeutic potential o... |
Book: The Healing Po... |
2009 |
| Benzenhöfer U, Passie T |
Rediscovering MDMA ecstasy: the role of the American chemist Alexander... |
Addiction |
2010 |
| Mithoefer MC, Wagner MT, ... |
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assi... |
J Psychopharmacol |
2011 |
| Johnston TH, Millar Z, Hu... |
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxi... |
FASEB J |
2012 |
| Mithoefer MC, Wagner MT, ... |
Durability of improvement in posttraumatic stress disorder symptoms an... |
J Psychopharmacol |
2012 |
| Oehen P, Traber R, Widmer... |
A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymeth... |
J Psychopharmacol |
2013 |
| Danforth AL, Struble CM, ... |
MDMA-assisted therapy: A new treatment model for social anxiety in aut... |
Prog Neuropsychophar... |
2016 |
| Baggott MJ, Coyle JR, Sie... |
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feeling... |
J Psychopharmacol |
2016 |
| Amoroso T, Workman M |
Treating posttraumatic stress disorder with MDMA-assisted psychotherap... |
J Psychopharmacol |
2016 |
| Pinterova N, Horsley RR, ... |
Synthetic Aminoindanes: A Summary of Existing Knowledge |
Front Psychiatry |
2017 |
| Passie T |
The early use of MDMA ('Ecstasy') in psychotherapy (1977-1985) |
Drug Science, Policy... |
2018 |
| Danforth AL, Grob CS, Str... |
Reduction in social anxiety after MDMA-assisted psychotherapy with aut... |
Psychopharmacology (... |
2018 |
| Heifets BD, Malenka RC |
Disruptive Psychopharmacology |
JAMA Psychiatry |
2019 |
